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Cholinergic-Monoamine Systems, 
Depression, and Panic 
To the Editor: 
Janowsky et al. (1972) suggested that aberrant 
cholinergic mechanisms may be involved in the path- 
ogenesis of depression, but the possibility that cho- 
linergic systems may be linked to the pathophysiol- 
ogy of panic disorder, an entity related to depressive 
disorders, has not yet been proposed. There is some 
reason to hypothesize that this link exists. I would 
like to suggest that it may be of heuristic value to 
consider a possible role for abnormal interaction of 
cholinergic and aminergic systems in the pathogen- 
esis of coexisting major depressive disorder (MDD) 
and panic attacks. 
Leckman et al. (1983) demonstrated the associ- 
ation of panic and depressive disorders. MDD com- 
bined with panic disorder in index probands predicted 
a marked increase in the incidence of both disorders 
in first-degree relatives. The authors suggested these 
disorders may share underlying mechanisms. Jan- 
owsky et al. (1983, 1984, 1985) have laid a foun- 
dation for discussing this topic. These investigators 
proposed that effects of stress and anxiety may be 
mediated by muscarinic cholinergic systems pos- 
sessing a capacity to activate adrenergic networks. 
Acetylcholine can simultaneously produce behav- 
ioral, cardiovascular, and neuroendocrine effects 
characterizing stress, anxiety, and MDD. There is 
evidence that cholinergic systems are involved in the 
pathophysiology of the affective disorders. Cholin- 
ergic overdrive produces depressed affect and somatic 
and psychic symptoms of spontanously occurring 
anxiety (Rowntree et al. 1950; Bowers et al. 1964; 
Dilsaver et al. 1983). Central cholinergic systems 
also regulate blood pressure and heart rate and acti- 
vate adrenergic neurons associated with elevation of 
these parameters (features of anxiety and stress re- 
sponse) (Brezenoff 1973; Brezenoff et al. 1979; Bre- 
zenoff and Gioliano 1982). The hypothesis that ab- 
normalities of the interregulation of cholinergic and 
monoaminergic systems account for the association 
of panic and affective disorders could be a testable 
means of bridging the pathophysiologies of these dis- 
orders. Epidemiological studies and pharmacological 
investigations lend themselves to this hypothesis. 
Nearly 50 years ago, Lindemann and Finesinger 
(1940) reported that norepinephrine and methacho- 
line, a peripherally active muscarinic agonist, pro- 
duced panic attacks in 1 l/20 and 9120 patients with 
histories of panic attacks, respectively. Thus, 
cholinergic and ammergic drugs can produce a panic 
attack in susceptible subjects. Granted. this may be 
a nonspecific effect. Specificity would be an issue 
that needs to be examined. However. the effective 
ness of these drugs in producing the attacks is con- 
Gstent with autonomic physiology. Muscarinic ago- 
nists precipitate release of catecholamines from the 
adrenal medulla and cardiac tissues. This effect is w 
potent that an orgamsm that is initially 111 a hyper 
cholinergic state can quickly enter a hyperadrenergic 
state. Small doses of intravenously administered acc- 
tylcholine produce bradycardia. generalized vasodi- 
latation. and a fall in blood pressure. Houcver, these 
initial effects arc quickly followed by rellex tachy~ 
cardia and vasoconstriction via a baroreceptor rc- 
aponse. In sufficient doses. acetylcholinc stimulates 
the release of catecholamines and activates sympa 
thetic ganglia (Taylor 1980). These latter effects bring 
about the hypcrcatecholaminergic stale. 
Pathologically pcrturhablc cholincr:]~. xy\tcrn\ 
threaten to mobilize 1110noiltillIierFIC’ nct\i arks I 1111 
SIVCF and (ire&n 1 0X-I) I‘hcrc I\ strong c\ idcncc 
that thij occurs. In addition to Imtlmg\ noted abolt. 
sc~cral other points ;uc also supporti\c Xluscarimc 
agonists caujc i I k “~apl” cIt’c‘cT\- wIi1cI1 arc alonc 
charactwstlcs of tright or ‘rcvcrc twr. am! i 21 rcleasc 
catecholammes (epincphrine and norcpmcphrinc) from 
the adrcnai medulla. Epinephrlnc Icads tcr &t P-adrcn 
ergic effect and a greater rcductlon in blood pressure 
due to vasodilatation. Mu!carinic agoni\!\ also act 
directly upon central mcchamms regulating neuro 
vcgetativc functions and cu-adrenergic neuron\ to trlf 
gcr the release ot norcpinephinc. For example. thcrc 
arc muscarlnic receptors on adrencrpic ncurom (Eh 
Icrt et al. 19X.3: Sorschcr and Dil\avei- IOXSi which 
promote tho relcasc r>l norcpincphrinc 
Elegant means of testing the hypothesl\ proposed 
are not currently available. but basic strategies arc 
possible. For example. the locus cerulcu\ has been 
implicated in the genesis of anxtcty statca This struc- 
ture interacts with cholinergic structures 111 the rcg 
ulation ot. REM-non-REM transitions and can be 
functionally isolated in order to study the physiology 
of sleep in intact animals. These studies. recently 
reviewed by Dilsavcr and Grcden ( I983 i. provide a 
model after which the interaction of cholinergic and 
monoaminergic systems in the pathophysiology 01 
coexisting MDD and panic might be patterned. 
in conclusion, the hypothesis set forth is of po- 
tential value in studying the pathophysiology of panic 
disorder occurring in the context of affective disease. 
Pamc disorder outside of this context may be a tiri 
ferent etiological emit! 
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I.lnivcrslty of Michigan 
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Within-session Data 
To the Editor: 
Early studies on neuroleptic effects in animal be- 
havior paradigms revealed response suppression in 
several different tests of unconditioned motor behav- 
ior (Dews and Morse 1961). Although recent hy- 
potheses suggest that decreases in spontaneous activ- 
ity may be more related to motor side effects 
(extrapyramidal symptoms) in the clinical situation 
than to antipsychotic properties, overall rate reduc- 
tions in these procedures continue to be used for 
characterizing the behavioral effects of these drugs. 
Inherent in the formation of these hypotheses is the 
premise that other, nonmotoric behavioral conse- 
quences of neuroleptic administration, such as changes 
in arousal (Beninger 1982) or the hedonic impact of 
rewards (Wise et al. 1978), are better correlated with 
clinical efficacy. Response changes indicative of drug- 
induced alterations in these processes are typically 
observed at doses subthreshold for motor or perfor- 
mance impairment. 
A majority of studies designed to test neuroleptic 
effects on spontaneous motor activity in laboratory 
animals have employed photocell measures. When 
administered to rats in doses approximating those 
used therapeutically, haloperidol does not appear to 
impair activity in this procedure (Costa11 et al. 1983), 
whereas crossovers in an open field environment are 
significantly reduced (Schaefer and Michael 1984; 
Hard et al. 1985). Although it is not uncommon for 
drug effects to vary with the apparatus, closer ex- 
amination in our laboratory has revealed significant 
haloperidol-induced reductions in photocell activity 
during the later portion of a test session (Figure la). 
Interestingly, this same pattern of decline in loco- 
motor responses over time has also been observed for 
rearing and crossing in an open field (Figure 1, b and 
c). where the response function is even more pro- 
nounced. Examination of control response patterns 
in saline-injected rats reveals a gradual decline of 
mean response rates over five 2-min intervals in the 
photocell chamber; this pattern is conspicuously ab- 
sent in the open field, where controls rear and cross 
steadily over the IO-min session. Therefore, it ap- 
pears that this dose of haloperidol induces a signifi- 
cant habituation of responding in both experimental 
situations, but that this pattern is less readily dis- 
cemable when testing is conducted in the enclosed, 
darkened photocell chambers with white noise pre- 
sented (where control animals habituate quickly). 
These studies indicate that spontaneous motor ac- 
tivity may be a useful behavior for studying low-dose 
neuroleptic effects if within-session data are exam- 
ined. Thus, although overall session totals may fail 
to reveal significant behavioral changes induced by 
these antipsychotic agents (as was the case for both 
procedures employed here), subtle differences in tem- 
poral patterns of responding may be detected. Fur- 
thermore, as drug-treated rats responded at saline lev- 
els during the initial portion of the test sessions, 
subsequent habituation may reflect a neuroleptic-in- 
duced attenuation of arousal or attention to environ- 
mental stimuli. This finding, in conjunction with the 
observation that saline-injected animals do display a 
similar habituation when retested in the open field 
environment (unpublished observation), indicates that 
(within-session) temporal patterns of responding may 
be related to neuroleptic-enhanced filtering of irrel- 
evant sensory information in psychotic states, 
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